RecruitingPhase 3NCT07213674
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Sponsor: Amgen
Duarte, CA · Fullerton, CA · +43 more sites
Prostate Cancer clinical trials in Duarte, CA
30 recruiting prostate cancer studies with a site in Duarte, CA.
RecruitingPhase 3NCT07611110
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Sponsor: AstraZeneca
Duarte, CA · Irvine, CA · Newport Beach, CA · +25 more sites
RecruitingPhase not listedNCT04775355
Study to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therapy in Patients With Prostate Cancer
Sponsor: City of Hope Medical Center
Duarte, CA
RecruitingPhase 1NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Sponsor: Eli Lilly and Company
Duarte, CA · La Jolla, CA · Los Angeles, CA · +20 more sites
RecruitingPhase 1NCT03460977
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Sponsor: Pfizer
Anaheim, CA · Duarte, CA · +42 more sites
RecruitingPhase 2NCT05691465
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
Sponsor: National Cancer Institute (NCI)
Duarte, CA · Los Angeles, CA · +10 more sites
RecruitingPhase 1 / Phase 2NCT07590934
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
Sponsor: AstraZeneca
Duarte, CA · Encino, CA · South Pasadena, CA · +9 more sites
RecruitingPhase 3NCT03678025
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Sponsor: SWOG Cancer Research Network
Antioch, CA · Clovis, CA · +331 more sites
RecruitingPhase 1NCT05997615
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Sponsor: Astellas Pharma Global Development, Inc.
Duarte, CA · Irvine, CA · Orange, CA · +5 more sites
RecruitingPhase 1NCT07114601
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Sponsor: Eli Lilly and Company
Duarte, CA · Santa Monica, CA · Stanford, CA · +13 more sites
RecruitingPhase 2NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Sponsor: Daiichi Sankyo
Duarte, CA · +12 more sites
RecruitingPhase 1 / Phase 2NCT07594106
REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
Sponsor: Regeneron Pharmaceuticals
Duarte, CA · +5 more sites
RecruitingPhase 1NCT05983432
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Sponsor: SystImmune Inc.
Beverly Hills, CA · Duarte, CA · Orange, CA · +19 more sites
RecruitingNot applicableNCT05804318
Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer
Sponsor: Varian, a Siemens Healthineers Company
Duarte, CA · Irvine, CA · +3 more sites
RecruitingPhase 1NCT04221542
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Amgen
Duarte, CA · Fullerton, CA · San Francisco, CA · +22 more sites
RecruitingPhase 1NCT05805371
PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer
Sponsor: City of Hope Medical Center
Duarte, CA
RecruitingPhase 2NCT06844383
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
Sponsor: Prostate Cancer Clinical Trials Consortium
Duarte, CA · La Jolla, CA · +6 more sites
RecruitingPhase 3NCT04423211
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Sponsor: ECOG-ACRIN Cancer Research Group
Arroyo Grande, CA · Burbank, CA · Carmichael, CA · +338 more sites
RecruitingPhase 2NCT07202247
Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial
Sponsor: City of Hope Medical Center
Duarte, CA
RecruitingPhase 2NCT05832086
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes
Sponsor: Stephen Freedland
Duarte, CA · Los Angeles, CA · +1 more sites
RecruitingPhase 1 / Phase 2NCT05652686
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Sponsor: Phanes Therapeutics
Duarte, CA · Los Angeles, CA · +13 more sites
RecruitingPhase 3NCT06592924
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Sponsor: Canadian Cancer Trials Group
Anaheim, CA · Arroyo Grande, CA · Baldwin Park, CA · +371 more sites
RecruitingPhase 1NCT06217822
First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
Sponsor: Bayer
Duarte, CA · +3 more sites
RecruitingPhase 1 / Phase 2NCT06267729
Study of AZD0754 in Participants With Metastatic Prostate Cancer
Sponsor: AstraZeneca
Duarte, CA · +12 more sites
RecruitingPhase 2NCT05806515
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Sponsor: SWOG Cancer Research Network
Arroyo Grande, CA · Burbank, CA · Carmichael, CA · +130 more sites
RecruitingPhase 2NCT04734730
Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer
Sponsor: City of Hope Medical Center
Duarte, CA
RecruitingPhase 2NCT07210086
Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R)
Sponsor: City of Hope Medical Center
Duarte, CA
RecruitingPhase 1NCT05107674
A Study of NX-1607 in Adults With Advanced Malignancies
Sponsor: Nurix Therapeutics, Inc.
Duarte, CA · Los Angeles, CA · San Francisco, CA · +7 more sites
RecruitingPhase 2NCT06134232
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
Sponsor: Dendreon
Duarte, CA · Fresno, CA · San Diego, CA · +28 more sites
Not yet recruitingPhase not listedNCT06194461
LTFU for All Cell and Gene Therapy Studies
Sponsor: AstraZeneca
Duarte, CA · Orange, CA · San Francisco, CA · +15 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.